Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Systemic Sclerosis Patients May Benefit from Targeted Stroke Screening

Lara C. Pullen, PhD  |  April 27, 2020

The team followed patients until the development of ischemic stroke, death or their last encounter. They used a Cox proportional regression model to estimate risk of ischemic stroke. Next, they calculated an adjusted risk by adjusting for cardiovascular comorbidities of hypertension, diabetes, atrial fibrillation, non-cerebrovascular atherosclerotic disease and hyperlipidemia, as well as the baseline use of aspirin, non-steroidal anti-inflammatory drugs and Medicare enrollment.

Higher Risk in SSc Patients
The researchers documented an incidence rate of ischemic stroke of 15.3 per 1,000 person-years in SSc patients with 12.2 per 1,000 person-years in the control cohort. The incidence of ischemic stroke between the two groups diverged early in the follow-up period. The divergence translated into an unadjusted hazard ratio of 1.28 and an adjusted hazard ratio of 1.21. The hazard ratio remained consistent for all sensitivity analyses.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Investigators conclude the risk of incident stroke or transient ischemic attack was 20–30% higher in individuals with SSc than in matched controls. Additionally, although cases had a significantly higher prevalence of traditional cardiovascular risk factors than controls, researchers note the increased risk of cerebrovascular disease in SSc patients was independent of these traditional cardiovascular risk factors. 

“In this study, we found scleroderma is associated with ischemic stroke,” says Gabriela Schmajuk, MD, a rheumatologist at UCSF and co-author of the paper. “This [finding] is important because we don’t traditionally think about large vessel disease, such as stroke and heart attack, in these patients. We were surprised by the number of patients in the VA system who we found with this diagnosis. We were able to put together the largest cohort of patients with scleroderma to date.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Schamjuk also emphasized that, although previous studies have found similar results in women, their study is much larger than any previously published research. This suggests rheumatologists should worry about ischemic stroke in women, as well as men.


Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

  1. Ying D, Gianfrancesco MA, Trupin L, et al. Increased risk of ischemic stroke in systemic sclerosis: A national cohort study of U.S. veterans. J Rheumatol. 2020 Jan;47(1):82–88.

Page: 1 2 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic Conditions Tagged with:brainriskstrokeSystemic sclerosissystemic sclerosis (SSc)

Related Articles

    Capillaroscopy a Safe and Direct Method for SSc Diagnosis

    June 13, 2011

    Seeing vessels clearly can help with discovery and timely treatment

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Progress Continues in Systemic Sclerosis

    March 1, 2010

    Advances in genetics and potential therapies shed new light on the disease

    The Heart-SCC Puzzle

    May 1, 2009

    Identifying and treating cardiac involvement in systemic sclerosis can be a challenge

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences